Cointime

Numab

company

About

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

  • 51 - 100

Highlights

Total Funding Amount
Fr22M
Funding Rounds
1
Investors
1
Investments
1
Lead Investments
1

Details

Last Funding Type
Series B
Last Funding Money Raised
Fr22M
Industries
Biopharma,Biotechnology,Health Care,Health Diagnostics,Life Science,Medical,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
51 - 100
Operating Status
Active

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases such as chronic inflammation and cancer. It features a plug-and-play platform that substantially reduces the random nature of the discovery process to predictably yield ready-to-develop multispecific biotherapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Fr22M
Numab has raised a total of Fr22M in funding over 2 rounds. Their latest funding was raised on Dec 12, 2019 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 12, 2019 Series B Fr22M 1 — — Detail

Investments

Number of Investments
Number of Lead Investments
1
1
Numab has made 1 investments. Their most recent investment was on Dec 12, 2019, when 3sbio raised Fr15M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 12, 2019 3sbio
Post-IPO Equity Fr15M Biotechnology Yes

Investors

Number of Lead Investors
Number of Investors
—
1
Numab is funded by 1 investors. 3sbio are the most recent investors.
Investor Name Lead Investor Funding Round
3sbio — Series B
Cointime
Содержание
компания